Pediatrix Medical Group (NYSE:MD) Posts Earnings Results, Beats Estimates By $0.07 EPS

Pediatrix Medical Group (NYSE:MD - Get Free Report) announced its quarterly earnings results on Friday. The company reported $0.44 EPS for the quarter, beating analysts' consensus estimates of $0.37 by $0.07, Briefing.com reports. Pediatrix Medical Group had a positive return on equity of 10.59% and a negative net margin of 12.58%. The company had revenue of $511.20 million during the quarter, compared to analyst estimates of $498.87 million. During the same period in the prior year, the company earned $0.29 earnings per share. The firm's revenue was up .9% on a year-over-year basis.

Pediatrix Medical Group Stock Up 23.5 %

NYSE MD traded up $2.89 during midday trading on Friday, hitting $15.21. 3,254,058 shares of the company traded hands, compared to its average volume of 871,407. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.38 and a quick ratio of 1.38. The company has a market cap of $1.31 billion, a PE ratio of -5.02, a price-to-earnings-growth ratio of 1.96 and a beta of 1.56. The company's 50-day simple moving average is $11.54 and its 200-day simple moving average is $9.36. Pediatrix Medical Group has a 52 week low of $6.62 and a 52 week high of $15.42.

Insider Buying and Selling at Pediatrix Medical Group

In other news, CFO C Marc Richards sold 32,562 shares of the firm's stock in a transaction on Friday, August 9th. The stock was sold at an average price of $10.08, for a total value of $328,224.96. Following the completion of the sale, the chief financial officer now owns 192,785 shares of the company's stock, valued at $1,943,272.80. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CFO C Marc Richards sold 32,562 shares of the firm's stock in a transaction on Friday, August 9th. The stock was sold at an average price of $10.08, for a total value of $328,224.96. Following the completion of the transaction, the chief financial officer now owns 192,785 shares in the company, valued at $1,943,272.80. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Laura A. Linynsky sold 7,000 shares of the firm's stock in a transaction on Tuesday, August 27th. The stock was sold at an average price of $11.16, for a total value of $78,120.00. Following the completion of the transaction, the director now owns 30,805 shares of the company's stock, valued at $343,783.80. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 68,100 shares of company stock valued at $701,889. 2.00% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of brokerages recently commented on MD. Truist Financial increased their price target on Pediatrix Medical Group from $10.00 to $13.00 and gave the company a "hold" rating in a research note on Monday, October 7th. StockNews.com upgraded Pediatrix Medical Group from a "sell" rating to a "hold" rating in a research report on Wednesday, August 7th. Jefferies Financial Group upgraded Pediatrix Medical Group from a "hold" rating to a "buy" rating and upped their price objective for the company from $8.00 to $14.00 in a research report on Thursday, September 26th. Finally, UBS Group upped their price objective on Pediatrix Medical Group from $9.00 to $10.50 and gave the company a "neutral" rating in a research report on Friday, August 9th. Five research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $10.90.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.